Research Funding

NDED SBIR/STTR Matching Funds

The Nebraska Department of Economic Development offers an SBIR/STTR matching grant program. They provide a 65%, up to $100,000, match to Nebraska recipients of Phase I and Phase II awards. They also offer a $5,000 Phase 0 Planning grant to Nebraska businesses applying for open SBIR or STTR solicitations. This grant can help pay for a grant writer, technical review, or salaries directly related to writing the proposal.

 

2016 L’Oreal USA for Women in Science Fellowship Program

Deadline:  Friday, February 5, 2016

The L’Oréal USA For Women in Science fellowship program awards five women postdoctoral scientists annually with grants of $60,000 each for their contributions in Science, Technology, Engineering and Math (STEM) fields and commitment to serving as role models for younger generations. The program is the U.S. component of the L’Oreal-UNESCO For Women in Science International Fellowships. Celebrating its twelfth year in the U.S., the For Women in Science program has awarded 60 postdoctoral women scientists nearly $3 million in grants.

L’Oréal USA partners with the American Association for the Advancement of Science (AAAS) to manage the program’s application and peer-review process. Each year, the program attracts talented applicants from diverse STEM fields, representing some of the nation’s leading academic institutions and laboratories.

The application can be found here.

The eligibility criteria are as follows:

  • Must have a conferred PhD and have started in a postdoctoral research position by December 31, 2015
  • Must maintain the status of postdoctoral researcher throughout the fellowship year
  • Must be American born, naturalized citizen or permanent resident
  • Must be affiliated with a U.S. based academic or research institution
  • Must plan to conduct their postdoctoral studies and research in the U.S.
  • Must be involved in basic research in the life and physical/material sciences, engineering & technology, computer science and mathematics
  • Cannot be in a faculty position
  • Must commit to at least twenty hours of activity in support of women and girls in science (e.g. mentoring, classroom visits, media, events)
  • Must be available the week of October 4-7, 2016 for the For Women in Science Awards Week

The Selection Process
To ensure that the candidates who are selected represent scientific excellence, the program utilizes a two-phased application review process.
In the first round, applications are evaluated by experienced scientists in the candidates’ respective fields. In the second round, a distinguished Jury of eminent scientists evaluates the top-ranked candidates and selects the five winners.

Candidates are Evaluated for Overall Excellence with a Focus On:

  • Intellectual merit, academic records and accepted requisites for scholarly scientific study
  • Ability to plan and conduct research either as a member of a team or independently
  • Scientific excellence and appropriateness of proposed research
  • Evidence of originality, initiative and productivity
  • Choice of host institution and department mentor
  • Potential for career enhancement if awarded the Fellowship
  • Commitment to supporting women and girls in science

TO LEARN MORE

 

DoD Preannouncement for Peer Reviewed Medical Research

The Defense Health Program Department of Defense Peer Reviewed Medical Research Program

Funding Opportunities for Fiscal Year 2016

 The Fiscal Year 2016 (FY16) Defense Appropriations Act provides $278.7 million to the Department of Defense Peer Reviewed Medical Research Program (PRMRP).  The vision of the PRMRP is to improve the health and well-being of all military Service members, Veterans, and beneficiaries.  The PRMRP challenges the scientific and clinical communities to address one of the FY16 congressionally directed topic areas with original ideas that foster new directions in basic science and translational research; novel product development leading to improved therapeutic or diagnostic tools; synergistic, multidisciplinary research programs; or clinical trials that address an immediate clinical need.

The PRMRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications.  FY16 PRMRP Program Announcements and General Application Instructions are anticipated to be posted on Grants.gov by late March 2016.  Pre-application and application deadlines will be available when the Program Announcements are released.  This pre-announcement should not be construed as an obligation by the government.

Congressionally Directed Topic Areas.  The FY16 PRMRP will solicit research applications for the following 39 topics areas:

  • Acute Lung Injury
  • Antimicrobial Resistance
  • Chronic Migraine and Post-Traumatic Headache
  • Congenital Heart Disease
  • Constrictive Bronchiolitis
  • Diabetes
  • Dystonia
  • Emerging Infectious Diseases
  • Focal Segmental Glomerulosclerosis
  • Fragile X Syndrome
  • Hepatitis B
  • Hereditary Angioedema
  • Hydrocephalus
  • Inflammatory Bowel Disease
  • Influenza
  • Integrative Medicine
  • Interstitial Cystitis
  • Lupus
  • Malaria
  • Metals Toxicology
  • Mitochondrial Disease
  • Nanomaterials for Bone Regeneration
  • Nonopioid Pain Management
  • Pancreatitis
  • Pathogen-Inactivated Dried Plasma
  • Polycystic Kidney Disease
  • Post-Traumatic Osteoarthritis
  • Psychotropic Medications
  • Pulmonary Fibrosis
  • Respiratory Health
  • Rett Syndrome
  • Rheumatoid Arthritis
  • Scleroderma
  • Sleep Disorders
  • Tinnitus
  • Tuberculosis
  • Vaccine Development for Infectious Disease
  • Vascular Malformations
  • Women’s Heart Disease

 Military Relevance:  Relevance to the healthcare needs of the military Service members, Veterans, and beneficiaries is a key feature of each FY16 PRMRP award mechanism.

Clinical Trial Award

Assistant Professor level or above (or equivalent)

Supports the rapid implementation of clinical trials of novel interventions with the potential to have a significant impact on patient care in the topic area(s) of interest.

Proposed projects may range from small proof-of-concept trials through large-scale, definitive trials.

Investigational New Drug or Investigational Device Exemption applications, if needed, should be submitted to the Food and Drug Administration before the PRMRP Grants.gov application submission deadline.

Preproposal submission is required; application submission is by invitation only

Funding limit not defined; requested funding must be appropriate for the scope of work proposed

Maximum period of performance is 5 years

Discovery Award

All Investigators

Supports the exploration of a highly innovative new concept or untested theory.

Not intended to support the logical progression of an already established line of questioning.

Clinical trials will not be funded.

Reviewers will be blinded to the identity of the Principal Investigator (PI), collaborators, and their organization(s)

Maximum of $200,000 for direct costs (plus indirect costs)

Maximum period of performance is 18 months

 

Focused Program Award

Full Professor level or above (or equivalent)

Supports a synergistic, multidisciplinary research program of at least four distinct but complementary projects addressing an overarching goal in one of the topic areas listed directly above. Projects should work together to answer critical questions, resolve differing hypotheses, and translate laboratory findings to clinical applications. Projects may range from exploratory/ hypothesis-developing through small-scale clinical trials that together will address the overarching goal/question. Research team of highly qualified, multidisciplinary project leaders should be led by a PI with demonstrated success in directing large, focused projects.

Preproposal submission is required; application submission is by invitation only.

Maximum of $10 million for total costs (includes direct and indirect costs)

Maximum period of performance is 5 years

 

Investigator-Initiated Research Award

Assistant Professor level or above (or equivalent)

Supports research that will make an original and important contribution to the field of research or patient care in the topic area(s) of interest.

Partnering PI Option available.

Clinical trials will not be funded.

Preproposal submission is required; application submission is by invitation only.

Maximum of $1.2 million for direct costs (plus indirect costs)

Maximum of $1.5 million for direct costs (plus indirect costs) for applications including a Partnering PI Option

Maximum period of performance is 3 years

Technology/ Therapeutic Development Award

Assistant Professor level or above (or equivalent)

Supports the development of diagnostics or therapies that have the potential to make a strong impact on patient care in the topic area(s) of interest.

Product-oriented (e.g., device, drug, clinical guidelines).

Clinical trials will not be funded.

Preproposal submission is required; application submission is by invitation only

Maximum of $3.0 million for direct costs (plus indirect costs)

Maximum period of performance is 3 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government’s single-entry portal, Grants.gov.  Submission deadlines are not available until the Program Announcements are released.  Requests for email notification of the Program Announcements’ release may be sent to help@ebrap.org.  For more information about the PRMRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Public Affairs

301-619-9783

mailto:usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil

Classification: UNCLASSIFIED Caveats: NONE